Bausch Health has the GF Score of 48, which implies that the company
might have
Worst future performance potential, or not enough data.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Bausch Health
might have
Worst future performance potential, or not enough data.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Bausch Health (MEX:BHCN) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Bausch Health GF Score Related Terms
MEX:BHCN vs ZTS: GF Score Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bausch Health GF Score vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bausch Health's GF Score distribution charts can be found below:
* The bar in red indicates where Bausch Health's GF Score falls into.
Bausch Health (MEX:BHCN) has a GF Score of 48 as of Jun. 25, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Bausch Health and its competitors. This is 11% below median its historical median of 54.00. Over the past decade, Bausch Health's GF Score has ranged from 2.00 to 78.00.
Is Bausch Health's GF Score too high?
Bausch Health's current GF Score of 48 is 11% below median its 10-year median of 54.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 78.00. Overall, Bausch Health has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's GF Score compare to ZTS?
Bausch Health's GF Score of 48 can be compared against companies in the Drug Manufacturers industry. Historically, Bausch Health's own GF Score has ranged from 2.00 to 78.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Bausch Health and its competitors. Bausch Health's current GF Score is 48, which is 11% below median its own 10-year median of 54.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Based on GuruFocus' analysis, Bausch Health (MEX:BHCN) is currently considered Possible Value Trap. The stock's GF Value™ is MXN188.23, compared to a current price of MXN85.44 — trading 54.6% below its estimated fair value. The current GF Score is 48, which is 11% below median its 10-year median of 54.00. Bausch Health's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Bausch Health (MEX:BHCN), the current GF Score is 48 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bausch Health (MEX:BHCN) Overvalued in 2026?
Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued.
The current stock price of MXN85.44 is trading 54.6% below its estimated GF Value™ of MXN188.23.
GuruFocus considers Bausch Health to be Possible Value Trap.
Key valuation signals for MEX:BHCN:
GF Score: 48 (11% below median its 10-year median of 54.00)
GF Value™: MXN188.23 vs. price of MXN85.44 (54.6% below fair value)
No single metric tells the full story. See the MEX:BHCN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
48GF Score
Get the complete analysis for MEX:BHCN
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:BHCN has been successfully added to your 